Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 5Myeloid 5Lymphoid 2Plasma cell 1Classical hematology 1

Conditions

Lymphoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 7Leukemia 7Hodgkin Disease 6Leukemia, Lymphocytic, Chronic, B-Cell 5Multiple Myeloma 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Sarcoma 3Neoplasms 2Myelodysplastic Syndromes 2Fatigue 2Weight Loss 1Vaginal Neoplasms 1Uterine Neoplasms 1Thyroid Neoplasms 1Thrombocytopenia 1Splenomegaly 1Sleep Initiation and Maintenance Disorders 1Sezary Syndrome 1Pyloric Stenosis, Hypertrophic 1Patient Participation 1Ovarian Cysts 1Osteosarcoma 1Osteonecrosis 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1

Interventions

Cyclophosphamide 172fludarabine phosphate 132Tacrolimus 100Mycophenolic Acid 92fludarabine 90Busulfan 88Whole-Body Irradiation 83Peripheral Blood Stem Cell Transplantation 77Antilymphocyte Serum 71Melphalan 69Filgrastim 63Cyclosporine 62Methotrexate 54Radiotherapy 40Thiotepa 39Cord Blood Stem Cell Transplantation 35Granulocyte Colony-Stimulating Factor 34Stem Cell Transplantation 32thymoglobulin 29Sirolimus 27Methylprednisolone 26Rituximab 24Cytarabine 23Clofarabine 23Etoposide 22Alemtuzumab 20Azacitidine 17Specimen Handling 14Cyclosporins 13sargramostim 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Myelodysplastic Syndromes × Surveys and Questionnaires × Lymphoid × Clear all
NCT00510315 2020-12-07

Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant

Memorial Sloan Kettering Cancer Center

Completed
11 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Aplastic, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms

NCT01875237 2019-07-16

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

M.D. Anderson Cancer Center

Phase 1/2 Terminated
3 enrolled 15 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡